Bilcare Ltd

Bilcare Ltd

Next 500 2024
+ 12 More
+ 12 More
OVERVIEW
FINANCIALS

About

Bilcare is a trailblazer in the Indian pharmaceutical and healthcare sectors. It offers specialty polymer films and aluminium foils for the packaging of pharmaceutical products that can come in solid dosage forms. Its packaging innovations include blister foils and films, lidding foils, CR foils, and laminates. Its R&D department is primarily engaged in the study of formulation stability, packaging trials and audits, and designing and developing blister foils.With an annual manufacturing capacity of 5000 tonnes and operating procedures within the US Food and Drug Administration guidelines, Bilcare exports its products to more than 100 countries globally. Some of its notable clients include Cipla, Sun Pharma, Serum Institute of India, Novartis, and Procter & Gamble.

Incorporation Year: 1987
Headquarters: Pune
Top Management: Ankita J. Kariya
Industry: Pharma

Featured In Fortune India Ranking

Fortune 500 India
#498(2020)
#357(2018)
#384(2017)
#373(2016)
#353(2015)
#315(2014)
#269(2013)
#246(2012)
#314(2011)
#494(2010)
#498(2020)#357(2018)#384(2017)#373(2016)#353(2015)#315(2014)#269(2013)#246(2012)#314(2011)#494(2010)
Ranking Trend Fortune 500 India
Next 500 India
#478(2024)#456(2023)#408(2022)
#478(2024)#456(2023)#408(2022)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
789
(INR Cr)
Net Operating Income
747
(INR Cr)
Assets
1,406
(INR Cr)
Profit
-33
(INR Cr)
Net Worth
498
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
789
-39.1%
1295
43.8%
900
32.4%
680
-63.8%
1878
-38.4%
3051
-2.9%
3141
16.6%
2693
-10.0%
2992
11.4%
2687
-13.8%
3116
-13.1%
3587
-2.2%
3667
57.0%
2336
119.1%
1066
22.0%
874
-
Net Operating Income
(INR Cr)
747
-23.88%
982
16.21%
845
35.65%
623
-65.92%
1827
-39.04%
2997
7.87%
2778
5.53%
2633
1.15%
2603
-3.32%
2692
-12.07%
3062
-13.67%
3547
-2.61%
3642
59.27%
2287
118.22%
1048
22.41%
856
31.56%
Profit
(INR Cr)
-33
-
15
-
-13
-
-21
-
-104
-
-455
-
-201
-
-85
-
-85
-
-216
-
-113
-
40
-71.0%
137
-7.4%
148
26.1%
117
41.0%
83
-
Assets
(INR Cr)
1406
4.4%
1346
53.5%
877
-2.3%
898
-5.3%
948
-62.4%
2524
-8.2%
2748
-4.2%
2870
-5.5%
3035
-14.6%
3554
-3.5%
3684
2.0%
3613
22.1%
2959
22.8%
2409
63.7%
1472
1.8%
1446
-
Net Worth
(INR Cr)
498
141.2%
206
174.6%
75
-12.9%
86
-20.3%
108
255.1%
-70
-117.5%
400
-34.8%
614
-13.9%
713
-35.0%
1096
-17.2%
1324
-0.1%
1325
-0.6%
1334
25.3%
1065
22.0%
873
76.0%
496
26.2%
Employee Cost
(INR Cr)
72
0.9%
71
20.2%
59
7.2%
55
-85.1%
371
-39.9%
617
10.5%
559
6.5%
524
2.7%
510
-6.8%
548
-2.7%
563
6.0%
531
-1.7%
540
63.3%
331
243.2%
96
11.6%
86
-
Interest Cost
(INR Cr)
82606976174283249176151236217167165994439
Cash & Bank Balance
(INR Cr)
36314057649110012411015610694173178152105
Total Debt
(INR Cr)
756639690677707227020892014212223112146210413711190599950

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues -1.2%---------1.1%3.7%6.3%11.0%9.5%
Profit As % Of Assets -1.1%---------1.1%4.6%6.1%7.9%5.7%
Profit As % Of Networth -7.3%---------3.0%10.2%13.9%13.4%16.7%
Interest Cost to EBITDA % 251.6%-121.3%163.1%395.8%167.9%158.3%93.6%-158.0%89.4%46.4%34.5%28.7%18.1%21.1%
Debt to Equity Ratio 1.523.099.187.856.53-5.223.282.982.111.621.591.031.120.691.92
RONW --8.3%---------4.2%11.2%15.1%17.1%18.7%
ROCE 0.0%2.8%0.0%0.0%0.0%0.0%0.0%0.0%0.0%1.1%3.0%7.5%13.2%15.5%14.4%12.5%